Horizon Pharma Expands U.S. Headquarters with Opening of Chicago Office
News Feb 24, 2015
Horizon Pharma plc has announced that it has opened a Chicago office.
The office, which is located at 150 South Wacker Drive, will primarily house commercial, corporate analytics and business development staff.
"More than twenty-five percent of our Illinois employees live in the City of Chicago and we felt it was important to establish a city presence in order to assist our employees in maximizing their personal and professional potential," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma, plc. "As one of the fastest growing biopharmaceutical companies in Illinois, a city presence offers access to top talent and easier access to the growing biotech and biopharma community."
"I am pleased that Horizon Pharma recognizes the thriving healthcare economy in Chicago and is making this investment in the city," said Mayor Rahm Emanuel. "Chicago's diverse and deep pool of talent remains a significant driver in companies like this making the decision to locate here."
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019